Schlaepfer, T, Pearlson, G, Wong, D, Marenco, S, Dannals, R. PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry
1997; 154: 1209–13.
Brody, A, Olmstead, R, London, E, Farahi, J, Meyer, J, Grossman, P, Lee, G, Huang, J, Hahn, E, Mandelkern, M. Smoking-induced ventral striatum dopamine release. Am J Psychiatry
2004; 161: 1211–8.
Boileau, I, Assaad, J, Pihl, R, Benkelfat, C, Leyton, M, Diksic, M, Tremblay, R, Dagher, A. Alcohol promotes dopamine release in the human nucleus accumbens. Synapse
2003; 49: 226–31.
Volkow, N, Wang, G, Fowler, J, Logan, J, Gatley, S, Wong, C, Hitzemann, R, Pappas, N. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J Pharmacol Exp Ther
1999; 291: 409–15.
Gerrits, M, Ramsey, N, Wolterink, G, Van Ree, J. Lack of evidence for an involvement of nucleus accumbens dopamine D1 receptors in the initiation of heroin self-administration in the rat. Psychopharmacology
1994; 114: 486–94.
Di Chiara, G, Imperato, A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA
1988; 85: 5274–8.
Volkow, N, Wang, G, Fowler, J, Logan, J, Gatley, S, Hitzemann, R, Chen, A, Dewey, S, Pappas, N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature
1997; 386: 830–3.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD–10).
World Health Organization, 1992.
Gunn, R, Lammertsma, A, Hume, S, Cunningham, V. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage
1997; 6: 279–87.
Mawlawi, O, Martinez, D, Slifstein, M, Broft, A, Chatterjee, R, Hwang, D, Huang, Y, Simpson, N, Ngo, K, Van Heertum, R, Laruelle, M. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab
2001; 21: 1034–57.
Jenkinson, C, Layte, R, Wright, L, Coulter, A. The UK SF-36: An Analysis and Interpretation Manual. A Guide to Health Status Measurement with Particular Reference to the Short Form 36 Health Survey.
University of Oxford, Department of Public Health and Primary Care, Health Services Research Unit, 1996.
Eysenck, H, Eysenck, S. Manual of the Eysenck Personality Scales (EPS Adult).
Hodder and Stoughton, 1971.
Gossop, M, Darke, S, Griffiths, P, Hando, J, Powis, B, Hall, W, Strang, J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction
1995; 90: 607–14.
Anton, R, Moak, D, Latham, P. The Obsessive Compulsive Drinking Scale. A new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry
1996; 53: 225–31.
Martin, W, Sloan, J, Sapira, J, Jasinski, D. Physiologic, subjective and behavioural effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin Pharmacol Ther
1971; 12: 245–58.
Jasinski, D. Assessment of the abuse potential of morphine-like drugs (methods used in man). In Drug Addiction I: Morphine, Sedative/Hypnotic and Alcohol Dependence (ed Martin, W): 197–258. Springer-Verlag, 1977.
Spielberger, C, Gorsuch, R, Lushene, R, Vagg, P, Jacobs, G. Manual for the State-Trait Anxiety Inventory.
Consulting Psychologists' Press, 1983.
Beck, A, Ward, C, Mendelson, M, Mock, J, Erbaugh, J. An inventory for measuring depression. Arch Gen Psychiatry
1961; 4: 561–71.
Law, F, Bailey, J, Allen, D, Melichar, J, Myles, J, Mitcheson, M, Lewis, J, Nutt, D. The feasibility of abrupt methadone–buprenorphine transfer in British opiate addicts in an outpatient setting. Addict Biol
1997; 2: 191–200.
Melichar, J, Myles, J, Eap, C, Nutt, D. Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test. Addict Biol
2003; 8: 59–66.
Crettol, S, Deglon, J, Besson, J, Croquette-Krokkar, M, Gothuey, I, Hammig, R, Monnat, M, Huttemann, H, Baumann, P, Eap, CB. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment. Clin Pharmacol Ther
2005; 78: 593–604.
Dienes-Nagy, A, Rivier, L, Giroud, C, Augsburger, M, Mangin, P. Method for quantification of morphine and its 3- and 6-glucuronides, codeine, codeine glucuronide and 6-monoacetylmorphine in human blood by liquid chromatography–electrospray mass spectrometry for routine analysis in forensic toxicology. J Chromatogr A
1999; 854: 109–18.
Ridenour, T, Maldonado-Molina, M, Compton, W, Spitznagel, E, Cottler, L. Factors associated with the transition from abuse to dependence among substance abusers. Implications for a measure of addictive liability. Drug Alcohol Depend
2005; 80: 1–14.
Martinez, D, Gil, R, Slifstein, M, Hwang, D, Huang, Y, Perez, A, Kegeles, L, Talbot, P, Evans, S, Krystal, J, Laruelle, M, Abi-Dargham, A. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry
2005; 58: 779–86.
Wang, G, Volkow, N, Fowler, J, Logan, J, Abumrad, N, Hitzemann, R, Pappas, N, Pascani, K. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacol
1997; 16: 174–82.
Hagelberg, N, Kajander, J, Nagren, K, Hinkka, S, Hietala, J, Scheinin, H. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man. Synapse
2002; 45: 25–30.
Hagelberg, N, Aalto, S, Kajander, J, Oikonen, V, Hinkka, S, Nagren, K, Hietala, J, Scheinin, H. Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects. Pain
2004; 109: 86–93.
Brody, AL, Mandelkern, MA, Olmstead, RE, Scheibal, D, Hahn, E, Shiraga, S, Zamora-Paja, E, Farahi, J, Saxena, S, London, ED, McCracken, JT. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry
2006; 63: 808–16.
Montgomery, AJ, Lingford-Hughes, AR, Egerton, A, Nutt, DJ, Grasby, PM. The effect of nicotine on striatal dopamine release in man. A [11C]raclopride PET study. Synapse
2007; 61: 637–45.
Mitrovic, I, Napier, TC. Mu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum. Eur J Neurosci
2002; 15: 257–68.
Laruelle, M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab
2000; 20: 423–51.
Robinson, T, Berridge, K. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev
1993; 18: 247–91.
Leyton, M, Boileau, I, Benkelfat, C, Diksic, M, Baker, G, Dagher, A. Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacol
2002; 27: 1027–35.
Breiter, H, Gollub, R, Weisskoff, R, Kennedy, D, Makris, N, Berke, J, Goodman, J, Kantor, H, Gastfriend, D, Riorden, J, Mathew, R, Rosen, B, Hyman, S. Acute effects of cocaine on human brain activity and emotion. Neuron
1997; 19: 591–611.